Sign in
8-K

Current Report

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-007054

Agreement ended · Shareholder rights changed · Other events

  • Item 1.02 Termination of a material definitive agreement
  • Item 3.03 Material modification to rights of security holders
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading tcrt-20260108.htm…